This census-based prospective longitudinal study followed 128 elderly individuals (aged ≥60) in a Brazilian municipality from 2010 to 2021.
BMC Geriatrics · 5 authors, 1 centre
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This census-based prospective longitudinal study followed 128 elderly individuals (aged ≥60) in a Brazilian municipality from 2010 to 2021.
This census-based prospective longitudinal study followed 128 elderly individuals (aged ≥60) in a Brazilian municipality from 2010 to 2021. At baseline, all participants were free of polypharmacy (defined as simultaneous use of ≥5 drugs). Data were collected via structured household surveys. The primary result was an incidence of polypharmacy of 46.1% over the 11-year period. Multivariate Poisson regression identified that the highest number of health problems was a statistically significant risk factor for developing polypharmacy (RR=1.177; 95% CI 1.093–1.267). The findings indicate a high incidence of polypharmacy in this primary care population, suggesting a need for policies and actions to promote rational drug use in the elderly.